Titre : Vaccins antiviraux

Vaccins antiviraux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Tissue Plasminogen Activator

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une infection virale ?

Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques.
Infections virales Tests diagnostiques
#2

Quels tests sont utilisés pour les vaccins antiviraux ?

Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité.
Vaccins antiviraux Tests sérologiques
#3

Les symptômes indiquent-ils un besoin de vaccin ?

Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin.
Symptômes Vaccins antiviraux
#4

Comment évaluer l'efficacité d'un vaccin ?

L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée.
Efficacité des vaccins Études cliniques
#5

Les tests de dépistage sont-ils nécessaires avant vaccination ?

Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination.
Dépistage Vaccination

Symptômes 5

#1

Quels symptômes nécessitent un vaccin antiviral ?

Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin.
Symptômes Vaccins antiviraux
#2

Les effets secondaires des vaccins sont-ils fréquents ?

Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers.
Effets secondaires Vaccins antiviraux
#3

Comment distinguer une infection d'un effet secondaire ?

Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires.
Infections virales Effets secondaires
#4

Les symptômes varient-ils selon le type de vaccin ?

Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle.
Types de vaccins Réponse immunitaire
#5

Les symptômes d'une infection virale sont-ils similaires ?

Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue.
Infections virales Symptômes

Prévention 5

#1

Comment les vaccins antiviraux préviennent-ils les infections ?

Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques.
Prévention Vaccins antiviraux
#2

À quel âge doit-on commencer la vaccination antivirale ?

L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance.
Vaccination Enfance
#3

Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?

Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin.
Vaccins antiviraux Grossesse
#4

Les vaccins protègent-ils contre toutes les souches virales ?

Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires.
Souches virales Vaccins antiviraux
#5

Quelle est l'importance de la vaccination de masse ?

La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus.
Vaccination de masse Immunité collective

Traitements 5

#1

Les vaccins antiviraux sont-ils des traitements ?

Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes.
Vaccins antiviraux Traitements antiviraux
#2

Quels traitements sont disponibles après infection ?

Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales.
Antiviraux Infections virales
#3

Les vaccins peuvent-ils réduire la gravité des symptômes ?

Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination.
Vaccins antiviraux Symptômes
#4

Les traitements sont-ils nécessaires après vaccination ?

Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination.
Vaccination Traitements antiviraux
#5

Les vaccins antiviraux nécessitent-ils des traitements préventifs ?

Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition.
Vaccins antiviraux Prévention

Complications 5

#1

Quelles complications peuvent survenir après vaccination ?

Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques.
Complications Réactions allergiques
#2

Les complications sont-elles fréquentes ?

Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques.
Complications Vaccins antiviraux
#3

Comment gérer les complications post-vaccinales ?

Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles.
Gestion des complications Vaccins antiviraux
#4

Les complications varient-elles selon le vaccin ?

Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition.
Profils de complications Vaccins antiviraux
#5

Les complications peuvent-elles affecter l'immunité ?

Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare.
Immunité Complications

Facteurs de risque 5

#1

Quels sont les facteurs de risque pour les infections virales ?

Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression.
Facteurs de risque Infections virales
#2

Les antécédents médicaux influencent-ils la vaccination ?

Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin.
Antécédents médicaux Vaccination
#3

Les voyages augmentent-ils le risque d'infection ?

Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques.
Voyages Infections virales
#4

Les personnes âgées ont-elles plus de risques ?

Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections.
Personnes âgées Complications
#5

Le mode de vie influence-t-il le risque d'infection ?

Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque.
Mode de vie Infections virales
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vaccins antiviraux : Questions médicales les plus fréquentes", "headline": "Vaccins antiviraux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vaccins antiviraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vaccins antiviraux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vaccins", "url": "https://questionsmedicales.fr/mesh/D014612", "about": { "@type": "MedicalCondition", "name": "Vaccins", "code": { "@type": "MedicalCode", "code": "D014612", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccins anti-adénovirus", "alternateName": "Adenovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D062705", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-adénovirus", "code": { "@type": "MedicalCode", "code": "D062705", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.024" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre le SIDA", "alternateName": "AIDS Vaccines", "url": "https://questionsmedicales.fr/mesh/D016915", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA", "code": { "@type": "MedicalCode", "code": "D016915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.050" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la COVID-19", "alternateName": "COVID-19 Vaccines", "url": "https://questionsmedicales.fr/mesh/D000086663", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la COVID-19", "code": { "@type": "MedicalCode", "code": "D000086663", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin ChAdOx1 nCoV-19", "alternateName": "ChAdOx1 nCoV-19", "url": "https://questionsmedicales.fr/mesh/D000090985", "about": { "@type": "MedicalCondition", "name": "Vaccin ChAdOx1 nCoV-19", "code": { "@type": "MedicalCode", "code": "D000090985", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085.063" } } }, { "@type": "MedicalWebPage", "name": "Ad26COVS1", "alternateName": "Ad26COVS1", "url": "https://questionsmedicales.fr/mesh/D000090984", "about": { "@type": "MedicalCondition", "name": "Ad26COVS1", "code": { "@type": "MedicalCode", "code": "D000090984", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.085.125" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le cytomégalovirus", "alternateName": "Cytomegalovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022482", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le cytomégalovirus", "code": { "@type": "MedicalCode", "code": "D022482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.120" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la dengue", "alternateName": "Dengue Vaccines", "url": "https://questionsmedicales.fr/mesh/D053059", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la dengue", "code": { "@type": "MedicalCode", "code": "D053059", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.162" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie à virus Ebola", "alternateName": "Ebola Vaccines", "url": "https://questionsmedicales.fr/mesh/D046129", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie à virus Ebola", "code": { "@type": "MedicalCode", "code": "D046129", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.205" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les herpèsvirus", "alternateName": "Herpesvirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022283", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les herpèsvirus", "code": { "@type": "MedicalCode", "code": "D022283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre la varicelle", "alternateName": "Chickenpox Vaccine", "url": "https://questionsmedicales.fr/mesh/D019433", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la varicelle", "code": { "@type": "MedicalCode", "code": "D019433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre le zona", "alternateName": "Herpes Zoster Vaccine", "url": "https://questionsmedicales.fr/mesh/D053061", "about": { "@type": "MedicalCondition", "name": "Vaccin contre le zona", "code": { "@type": "MedicalCode", "code": "D053061", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccin contre le zona", "alternateName": "Herpes Zoster Vaccine", "url": "https://questionsmedicales.fr/mesh/D053061", "about": { "@type": "MedicalCondition", "name": "Vaccin contre le zona", "code": { "@type": "MedicalCode", "code": "D053061", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.130.400" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus herpès simplex", "alternateName": "Herpes Simplex Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022301", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus herpès simplex", "code": { "@type": "MedicalCode", "code": "D022301", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.400" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie de Marek", "alternateName": "Marek Disease Vaccines", "url": "https://questionsmedicales.fr/mesh/D022501", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie de Marek", "code": { "@type": "MedicalCode", "code": "D022501", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.290.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins antigrippaux", "alternateName": "Influenza Vaccines", "url": "https://questionsmedicales.fr/mesh/D007252", "about": { "@type": "MedicalCondition", "name": "Vaccins antigrippaux", "code": { "@type": "MedicalCode", "code": "D007252", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.302" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre l'encéphalite japonaise", "alternateName": "Japanese Encephalitis Vaccines", "url": "https://questionsmedicales.fr/mesh/D022321", "about": { "@type": "MedicalCondition", "name": "Vaccins contre l'encéphalite japonaise", "code": { "@type": "MedicalCode", "code": "D022321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.320" } } }, { "@type": "MedicalWebPage", "name": "Vaccin contre la rougeole", "alternateName": "Measles Vaccine", "url": "https://questionsmedicales.fr/mesh/D008458", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la rougeole", "code": { "@type": "MedicalCode", "code": "D008458", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.404" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antiourlien", "alternateName": "Mumps Vaccine", "url": "https://questionsmedicales.fr/mesh/D009108", "about": { "@type": "MedicalCondition", "name": "Vaccin antiourlien", "code": { "@type": "MedicalCode", "code": "D009108", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.488" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les papillomavirus", "alternateName": "Papillomavirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D053918", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les papillomavirus", "code": { "@type": "MedicalCode", "code": "D053918", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.498" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18", "alternateName": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18", "url": "https://questionsmedicales.fr/mesh/D000068857", "about": { "@type": "MedicalCondition", "name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18", "code": { "@type": "MedicalCode", "code": "D000068857", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.498.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus para-influenza", "alternateName": "Parainfluenza Vaccines", "url": "https://questionsmedicales.fr/mesh/D022241", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus para-influenza", "code": { "@type": "MedicalCode", "code": "D022241", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.500" } } }, { "@type": "MedicalWebPage", "name": "Vaccins antipoliomyélitiques", "alternateName": "Poliovirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D023321", "about": { "@type": "MedicalCondition", "name": "Vaccins antipoliomyélitiques", "code": { "@type": "MedicalCode", "code": "D023321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin antipoliomyélitique inactivé", "alternateName": "Poliovirus Vaccine, Inactivated", "url": "https://questionsmedicales.fr/mesh/D011054", "about": { "@type": "MedicalCondition", "name": "Vaccin antipoliomyélitique inactivé", "code": { "@type": "MedicalCode", "code": "D011054", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623.500" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antipoliomyélitique oral", "alternateName": "Poliovirus Vaccine, Oral", "url": "https://questionsmedicales.fr/mesh/D011055", "about": { "@type": "MedicalCondition", "name": "Vaccin antipoliomyélitique oral", "code": { "@type": "MedicalCode", "code": "D011055", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.623.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre la maladie d'Aujeszky", "alternateName": "Pseudorabies Vaccines", "url": "https://questionsmedicales.fr/mesh/D022421", "about": { "@type": "MedicalCondition", "name": "Vaccins contre la maladie d'Aujeszky", "code": { "@type": "MedicalCode", "code": "D022421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.632" } } }, { "@type": "MedicalWebPage", "name": "Vaccins antirabiques", "alternateName": "Rabies Vaccines", "url": "https://questionsmedicales.fr/mesh/D011819", "about": { "@type": "MedicalCondition", "name": "Vaccins antirabiques", "code": { "@type": "MedicalCode", "code": "D011819", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.700" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les virus respiratoires syncytiaux", "alternateName": "Respiratory Syncytial Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022261", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les virus respiratoires syncytiaux", "code": { "@type": "MedicalCode", "code": "D022261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.730" } } }, { "@type": "MedicalWebPage", "name": "Vaccins anti-rotavirus", "alternateName": "Rotavirus Vaccines", "url": "https://questionsmedicales.fr/mesh/D022243", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-rotavirus", "code": { "@type": "MedicalCode", "code": "D022243", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.760" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antirubéoleux", "alternateName": "Rubella Vaccine", "url": "https://questionsmedicales.fr/mesh/D012411", "about": { "@type": "MedicalCondition", "name": "Vaccin antirubéoleux", "code": { "@type": "MedicalCode", "code": "D012411", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.779" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccin contre la rougeole, les oreillons et la rubéole", "alternateName": "Measles-Mumps-Rubella Vaccine", "url": "https://questionsmedicales.fr/mesh/D022542", "about": { "@type": "MedicalCondition", "name": "Vaccin contre la rougeole, les oreillons et la rubéole", "code": { "@type": "MedicalCode", "code": "D022542", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.779.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le SIDA simien", "alternateName": "SAIDS Vaccines", "url": "https://questionsmedicales.fr/mesh/D018449", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le SIDA simien", "code": { "@type": "MedicalCode", "code": "D018449", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.790" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antivariolique", "alternateName": "Smallpox Vaccine", "url": "https://questionsmedicales.fr/mesh/D012900", "about": { "@type": "MedicalCondition", "name": "Vaccin antivariolique", "code": { "@type": "MedicalCode", "code": "D012900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.859" } } }, { "@type": "MedicalWebPage", "name": "Vaccins contre les hépatites virales", "alternateName": "Viral Hepatitis Vaccines", "url": "https://questionsmedicales.fr/mesh/D014761", "about": { "@type": "MedicalCondition", "name": "Vaccins contre les hépatites virales", "code": { "@type": "MedicalCode", "code": "D014761", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccins anti-hépatite A", "alternateName": "Hepatitis A Vaccines", "url": "https://questionsmedicales.fr/mesh/D022362", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-hépatite A", "code": { "@type": "MedicalCode", "code": "D022362", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955.395" } } }, { "@type": "MedicalWebPage", "name": "Vaccins anti-hépatite B", "alternateName": "Hepatitis B Vaccines", "url": "https://questionsmedicales.fr/mesh/D017325", "about": { "@type": "MedicalCondition", "name": "Vaccins anti-hépatite B", "code": { "@type": "MedicalCode", "code": "D017325", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.955.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Vaccins contre le virus du Nil occidental", "alternateName": "West Nile Virus Vaccines", "url": "https://questionsmedicales.fr/mesh/D053060", "about": { "@type": "MedicalCondition", "name": "Vaccins contre le virus du Nil occidental", "code": { "@type": "MedicalCode", "code": "D053060", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.962" } } }, { "@type": "MedicalWebPage", "name": "Vaccin antiamaril", "alternateName": "Yellow Fever Vaccine", "url": "https://questionsmedicales.fr/mesh/D022341", "about": { "@type": "MedicalCondition", "name": "Vaccin antiamaril", "code": { "@type": "MedicalCode", "code": "D022341", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.894.899.970" } } } ], "about": { "@type": "MedicalCondition", "name": "Vaccins antiviraux", "alternateName": "Viral Vaccines", "code": { "@type": "MedicalCode", "code": "D014765", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yukai Huang", "url": "https://questionsmedicales.fr/author/Yukai%20Huang", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Xiao Guo", "url": "https://questionsmedicales.fr/author/Xiao%20Guo", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Yuancheng Zhou", "url": "https://questionsmedicales.fr/author/Yuancheng%20Zhou", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China." } }, { "@type": "Person", "name": "Dongying Liu", "url": "https://questionsmedicales.fr/author/Dongying%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } }, { "@type": "Person", "name": "Jingrui Mao", "url": "https://questionsmedicales.fr/author/Jingrui%20Mao", "affiliation": { "@type": "Organization", "name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy.", "datePublished": "2022-09-03", "url": "https://questionsmedicales.fr/article/36057550", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12886-022-02550-4" } }, { "@type": "ScholarlyArticle", "name": "The LRP1/CD91 ligands, tissue-type plasminogen activator, α", "datePublished": "2022-10-20", "url": "https://questionsmedicales.fr/article/36266319", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-22498-1" } }, { "@type": "ScholarlyArticle", "name": "Site-specific PEGylation of recombinant tissue-type plasminogen activator.", "datePublished": "2023-09-30", "url": "https://questionsmedicales.fr/article/37783360", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejpb.2023.09.017" } }, { "@type": "ScholarlyArticle", "name": "Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35913922", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0272257" } }, { "@type": "ScholarlyArticle", "name": "Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders.", "datePublished": "2023-02-24", "url": "https://questionsmedicales.fr/article/36901924", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms24054496" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Vaccins", "item": "https://questionsmedicales.fr/mesh/D014612" }, { "@type": "ListItem", "position": 5, "name": "Vaccins antiviraux", "item": "https://questionsmedicales.fr/mesh/D014765" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vaccins antiviraux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vaccins antiviraux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vaccins antiviraux", "description": "Comment diagnostiquer une infection virale ?\nQuels tests sont utilisés pour les vaccins antiviraux ?\nLes symptômes indiquent-ils un besoin de vaccin ?\nComment évaluer l'efficacité d'un vaccin ?\nLes tests de dépistage sont-ils nécessaires avant vaccination ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vaccins antiviraux", "description": "Quels symptômes nécessitent un vaccin antiviral ?\nLes effets secondaires des vaccins sont-ils fréquents ?\nComment distinguer une infection d'un effet secondaire ?\nLes symptômes varient-ils selon le type de vaccin ?\nLes symptômes d'une infection virale sont-ils similaires ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vaccins antiviraux", "description": "Comment les vaccins antiviraux préviennent-ils les infections ?\nÀ quel âge doit-on commencer la vaccination antivirale ?\nLes vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?\nLes vaccins protègent-ils contre toutes les souches virales ?\nQuelle est l'importance de la vaccination de masse ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vaccins antiviraux", "description": "Les vaccins antiviraux sont-ils des traitements ?\nQuels traitements sont disponibles après infection ?\nLes vaccins peuvent-ils réduire la gravité des symptômes ?\nLes traitements sont-ils nécessaires après vaccination ?\nLes vaccins antiviraux nécessitent-ils des traitements préventifs ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vaccins antiviraux", "description": "Quelles complications peuvent survenir après vaccination ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications post-vaccinales ?\nLes complications varient-elles selon le vaccin ?\nLes complications peuvent-elles affecter l'immunité ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vaccins antiviraux", "description": "Quels sont les facteurs de risque pour les infections virales ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes voyages augmentent-ils le risque d'infection ?\nLes personnes âgées ont-elles plus de risques ?\nLe mode de vie influence-t-il le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Tissue+Plasminogen+Activator#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection virale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les vaccins antiviraux ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité." } }, { "@type": "Question", "name": "Les symptômes indiquent-ils un besoin de vaccin ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un vaccin ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils nécessaires avant vaccination ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un vaccin antiviral ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin." } }, { "@type": "Question", "name": "Les effets secondaires des vaccins sont-ils fréquents ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers." } }, { "@type": "Question", "name": "Comment distinguer une infection d'un effet secondaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de vaccin ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle." } }, { "@type": "Question", "name": "Les symptômes d'une infection virale sont-ils similaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue." } }, { "@type": "Question", "name": "Comment les vaccins antiviraux préviennent-ils les infections ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques." } }, { "@type": "Question", "name": "À quel âge doit-on commencer la vaccination antivirale ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance." } }, { "@type": "Question", "name": "Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin." } }, { "@type": "Question", "name": "Les vaccins protègent-ils contre toutes les souches virales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires." } }, { "@type": "Question", "name": "Quelle est l'importance de la vaccination de masse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus." } }, { "@type": "Question", "name": "Les vaccins antiviraux sont-ils des traitements ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles après infection ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils réduire la gravité des symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination." } }, { "@type": "Question", "name": "Les traitements sont-ils nécessaires après vaccination ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination." } }, { "@type": "Question", "name": "Les vaccins antiviraux nécessitent-ils des traitements préventifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après vaccination ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques." } }, { "@type": "Question", "name": "Comment gérer les complications post-vaccinales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles." } }, { "@type": "Question", "name": "Les complications varient-elles selon le vaccin ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter l'immunité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les infections virales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils la vaccination ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques." } }, { "@type": "Question", "name": "Les personnes âgées ont-elles plus de risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 18/02/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

36 au total
└─

Vaccins anti-adénovirus

Adenovirus Vaccines D062705 - D20.215.894.899.024
└─

Vaccins contre le SIDA

AIDS Vaccines D016915 - D20.215.894.899.050
└─

Vaccins contre la COVID-19

COVID-19 Vaccines D000086663 - D20.215.894.899.085
└─

Vaccins contre le cytomégalovirus

Cytomegalovirus Vaccines D022482 - D20.215.894.899.120
└─

Vaccins contre la dengue

Dengue Vaccines D053059 - D20.215.894.899.162
└─

Vaccins contre la maladie à virus Ebola

Ebola Vaccines D046129 - D20.215.894.899.205
└─

Vaccins contre les herpèsvirus

Herpesvirus Vaccines D022283 - D20.215.894.899.290
└─

Vaccins antigrippaux

Influenza Vaccines D007252 - D20.215.894.899.302
└─

Vaccins contre l'encéphalite japonaise

Japanese Encephalitis Vaccines D022321 - D20.215.894.899.320
└─

Vaccin contre la rougeole

Measles Vaccine D008458 - D20.215.894.899.404
└─

Vaccin antiourlien

Mumps Vaccine D009108 - D20.215.894.899.488
└─

Vaccins contre les papillomavirus

Papillomavirus Vaccines D053918 - D20.215.894.899.498
└─

Vaccins contre les virus para-influenza

Parainfluenza Vaccines D022241 - D20.215.894.899.500
└─

Vaccins antipoliomyélitiques

Poliovirus Vaccines D023321 - D20.215.894.899.623
└─

Vaccins contre la maladie d'Aujeszky

Pseudorabies Vaccines D022421 - D20.215.894.899.632
└─

Vaccins antirabiques

Rabies Vaccines D011819 - D20.215.894.899.700
└─

Vaccins contre les virus respiratoires syncytiaux

Respiratory Syncytial Virus Vaccines D022261 - D20.215.894.899.730
└─

Vaccins anti-rotavirus

Rotavirus Vaccines D022243 - D20.215.894.899.760
└─

Vaccin antirubéoleux

Rubella Vaccine D012411 - D20.215.894.899.779
└─

Vaccins contre le SIDA simien

SAIDS Vaccines D018449 - D20.215.894.899.790
└─

Vaccin antivariolique

Smallpox Vaccine D012900 - D20.215.894.899.859
└─

Vaccins contre les hépatites virales

Viral Hepatitis Vaccines D014761 - D20.215.894.899.955
└─

Vaccins contre le virus du Nil occidental

West Nile Virus Vaccines D053060 - D20.215.894.899.962
└─

Vaccin antiamaril

Yellow Fever Vaccine D022341 - D20.215.894.899.970
└─└─

Vaccin ChAdOx1 nCoV-19

ChAdOx1 nCoV-19 D000090985 - D20.215.894.899.085.063
└─└─

Ad26COVS1

Ad26COVS1 D000090984 - D20.215.894.899.085.125
└─└─

Vaccin contre la varicelle

Chickenpox Vaccine D019433 - D20.215.894.899.290.130
└─└─

Vaccins contre les virus herpès simplex

Herpes Simplex Virus Vaccines D022301 - D20.215.894.899.290.400
└─└─

Vaccins contre la maladie de Marek

Marek Disease Vaccines D022501 - D20.215.894.899.290.500
└─└─

Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 D000068857 - D20.215.894.899.498.500
└─└─

Vaccin antipoliomyélitique inactivé

Poliovirus Vaccine, Inactivated D011054 - D20.215.894.899.623.500
└─└─

Vaccin antipoliomyélitique oral

Poliovirus Vaccine, Oral D011055 - D20.215.894.899.623.750
└─└─

Vaccin contre la rougeole, les oreillons et la rubéole

Measles-Mumps-Rubella Vaccine D022542 - D20.215.894.899.779.500
└─└─

Vaccins anti-hépatite A

Hepatitis A Vaccines D022362 - D20.215.894.899.955.395
└─└─

Vaccins anti-hépatite B

Hepatitis B Vaccines D017325 - D20.215.894.899.955.400
└─└─└─

Vaccin contre le zona

Herpes Zoster Vaccine D053061 - D20.215.894.899.290.130.400

Auteurs principaux

Yukai Huang

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.

Xiao Guo

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.

Yuancheng Zhou

2 publications dans cette catégorie

Affiliations :
  • Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China.

Dongying Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.

Jingrui Mao

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.

Yongai Xiong

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmaceutics, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.

Youcai Deng

2 publications dans cette catégorie

Affiliations :
  • Department of Hematology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China.

Xinghong Gao

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
  • Provincial Department of Education, Key Laboratory of Infectious Disease & Bio-Safety, Zunyi Medical University, Zunyi, Guizhou, China.

Chit Laa Poh

2 publications dans cette catégorie

Affiliations :
  • Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, Malaysia.
Publications dans "Vaccins antiviraux" :

Lianpan Dai

2 publications dans cette catégorie

Affiliations :
  • CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. dailp@im.ac.cn.
Publications dans "Vaccins antiviraux" :

Zhou Xing

2 publications dans cette catégorie

Affiliations :
  • McMaster Immunology Research Centre and Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada. Electronic address: xingz@mcmaster.ca.
Publications dans "Vaccins antiviraux" :

Scott B Halstead

1 publication dans cette catégorie

Affiliations :
  • , Rockville, MD, USA. halsteads@erols.com.
Publications dans "Vaccins antiviraux" :

Naina McCann

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: Naina.mccann@paediatrics.ox.ac.uk.
Publications dans "Vaccins antiviraux" :

Daniel O'Connor

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :

Teresa Lambe

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :

Andrew J Pollard

1 publication dans cette catégorie

Affiliations :
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :

Antonio Lembo

1 publication dans cette catégorie

Affiliations :
  • Department of Chemical Sciences, University of Naples Federico II, Naples, Italy; GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :

Antonio Molinaro

1 publication dans cette catégorie

Affiliations :
  • Department of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Publications dans "Vaccins antiviraux" :

Cristina De Castro

1 publication dans cette catégorie

Affiliations :
  • Department of Chemical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: cristina.decastro@unina.it.
Publications dans "Vaccins antiviraux" :

Francesco Berti

1 publication dans cette catégorie

Affiliations :
  • GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :

Sources (10000 au total)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy.

Diabetic retinopathy (DR) is a serious complication of longstanding type 2 diabetes mellitus (T2DM), a leading cause of blindness and visual disability in the world. The aim of this study is to compar... Among the T2DM patients enrolled in this study, 26 patients had DR (n = 26) while 29 were without DR (n = 29). The blood and tear samples were obtained from all participants. The level of PAI-1 and tP... Patients with DR had significantly longer disease duration and higher systolic blood pressure compared to those without DR. Serum PAI-1 level was significantly higher in patients with DR compared to t... The present study demonstrated a significantly greater serum PAI-1 levels in patients with DR compared to those without DR. No significant correlations between tears and serum PAI-1 and tPA were obser...

Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage.

Intracranial hemorrhage (ICH) is the most devastating complication of recombinant tissue plasminogen activator (rtPA) treatment in acute ischemic stroke patients. Data on rtPA-associated asymptomatic ... To determine the incidence, risk factors, characteristics, management, and clinical outcome of rtPA-associated aICH.... The data were retrieved from the Chiang Mai University Hospital Stroke Registry between 1995 and 2019. Consecutive ischemic stroke patients were included if they were 18 or older and received rtPA. St... Of 725 rtPA treated patients, 166 (16.0%, 95% confidence interval [CI] 13.4-18.9) had aICH, 50 (6.9%, 95% CI 5.2-9.0) had symptomatic ICH (sICH). Patients with aICH had more hemorrhagic infarctions (H... The rtPA-associated aICH increased the risk of morbidity and mortality outcomes. Further treatment consensus, guideline generation, or clinical trials focusing on the treatment of rtPA-associated aICH...

Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders.

Stressful events trigger a set of complex biological responses which follow a bell-shaped pattern. Low-stress conditions have been shown to elicit beneficial effects, notably on synaptic plasticity to...

Tissue plasminogen activator with prolonged dwell time effectively evacuates pleural effusions.

Fibrinolytic therapy can be effective for management of complex pleural effusions. Tissue plasminogen activator (tPA, 10 mg) and deoxyribonuclease (DNAse) every 12 h with a dwell time of one hour is a... Charts were reviewed and demographics, clinical data and treatment information were abstracted. Outcomes were assessed based on radiographic findings and need for surgery.... Two hundred and fifteen effusions in 207 patients (8 bilateral) were identified. 85% were either infectious or malignant. Two hundred and forty nine chest tubes were used: 84% were 10 Fr or 12 Fr and ... Low dose tPA daily with a 12 h dwell time may be as effective as the standard regimen of tPA and DNAse twice daily with one hour dwell. For most patients only three doses were required, and small pigt...

A Successful Treatment Approach in 2 Patients With Type 1 Plasminogen Deficiency: Intratracheal Application of Fresh Frozen Plasma and Tissue Plasminogen Activator.

Respiratory system involvement is common in congenital plasminogen deficiency. Although many treatment approaches have been tried, there is still no definitive treatment for respiratory system involve... We report 2 congenital plasminogen deficiency cases, who presented with severe respiratory symptoms, for whom a novel treatment modality was tried. After intravenous administration of FFP (fresh froze... Intratracheal administration of tissue plasminogen activator and FFP is an available treatment modality for patients with lung involvement. Fibrin plaques should be carefully removed and new lesion fo...

Successful Outcome in an Adolescent with Artery of Percheron Occlusion who was Treated with Tissue Plasminogen Activator.

Ischemic stroke is relatively rare in children, leading to a low level of suspicion and delayed diagnosis, particularly in cases of posterior circulation occlusion when symptoms are less indicative. O... We report a case of a 16-year-old male who presented to the pediatric emergency department with altered mental status. There was no history of trauma or intoxication. The main symptoms included confus...

Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.

The most severe complication associated with giant coronary aneurysm in children with Kawasaki disease is ischemic cardiomyopathy (ICM) caused by thrombosis. Addition of tissue plasminogen activator, ... Total four male KD patients with central thromboses in coronary aneurysm were treated in Pediatric Cardiology Department of Shengjing Hospital, China Medical University, from January 2020 to August 20... 4 young male KD patients had coronary aneurysm (CAA) complicated with total 7 occurrences of central thrombosis. These patients were given alteplase and heparin/oral Warfarin + Aspirin + Clopidogrel t... 1. Pediatric KD patients complicated with coronary aneurysm thrombosis are prone to recurrence of thrombosis. 2. In KD patients complicated with coronary aneurysm thrombosis, treatments described in M...